Invitrogen™ ProQuantum™ Human IL-1β Immunoassay Kit

Ref.: BL-RE-102016Manufacturer ref.: A355745 5 x 96 tests
€3,815.00 excl. VAT

L-interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as an inactive 31 kDa proform that is...

Accession number
P01584
Dose range
0.064 – 10 000 pg/ml
Sensitivity of the dosage
<0,05 pg/ml
Method of detection
Taqman™ PCR in real time
Product type
ProQuantum
Brand
Invitrogen

L-interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as an inactive 31 kDa proform that is...

L-interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive proform that accumulates in cytosol. The cleavage of pro-IL-1 beta in the active protein of 17 kDa requires the activation of inflammasomas, which are multi-protein complexes that respond to pathogens, stress conditions and other hazard signals. The activation of l'inflammasoma triggers the treatment of the precursor of caspase-1 in its active form, which in turn cleaves the pro-IL-1 beta. IL-1 beta n-a has no signal sequence peptide for the conventional ER/Golgi pathway and is secreted along the caspase-1 via an alternative mechanism and understood incompletely. Although the beta-IL-1 is most often secreted in its active form, the secretion of the uncleavened protein can be detectable under certain biological conditions. Il-1 beta signals through two receptors, IL-1RI and IL-1RII, both of which are shared with l的IL-1 alpha. The activity of the IL-1 beta may be moderated by the receptor antagonist IL-1 (IL-1RA), a protein produced by many types of cells that blocks receptor binding by competitive inhibition. IL-1 beta plays an important role in defending the innate host by triggering the production of other proinflammatory cytokines in target cells and by triggering acute phase responses to infection and injury. High levels of d的IL-1 beta have been associated with many chronic inflammatory conditions of d的IL-1 beta neutralizing the potential therapeutic value of antibodies.

Measurement range

Dose range: 0.064 – 10.000 pg/ml.

Duration of dosing

Total duration of dosing: 2 hours.

Target

Target: Human.

Samples

Sample type: Plasma, Serum, Surnatant (Serum volume, 2-5 μl; plasma, 2-5 μl; supernatant, 2-5 μl).

Marking

Marker: FAM™.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17123099
Specifications
Accession numberP01584
Dose range0.064 – 10 000 pg/ml
Sensitivity of the dosage<0.05 pg/ml
Method of detectionTaqman™ PCR in real time
Product typeProQuantum
Type of samplePlasma, Serum, Surnatant
Target speciesHuman
For use with (application)Quantification of cytokine proteins
For use with (equipment)qPCR instruments
Genetic identification (Enter)3553
Gene symbol(s)IL-1 ; IL1-BETA ; IL1F2
Contents of kitsDoage dilution stamp
Conjugate with A-antibodies
Conjugate B antibody
Dilution buffer of conjugate of antibodies
Standard
Master Mix
Ligase
Marker or dyeFAM ™
Quantity5 x 96 tests
Regulatory statusRUO
TargetHuman
Test time30 min.
Physical characteristics
Volume of sampleSerum, 2-5 μl; plasma, 2-5 μl; supernatant, 2-5 μl
Storage and shipping
Storage conditions-20°C
Total duration of dosing2 hours

Origin and customs

Manufacturer ref.A355745
Country of originUnited States
HS customs code2530 20 00 00
A question or a specific configuration?
Contact us for a quote.